Lurking in the shadows

Lurking in the shadows

Listen we knew that 2017 was going to be overly wacky but given what we are hearing now convinces us that we ain’t seen nothing yet. First it was Johnson and Johnson’s decision to exit diabetes, which in turn prompted Medtronic to become interested in LifeScan. Now word is spreading that Roche, yes Roche, is getting ready to attempt a comeback. Ok we know this sounds crazy but given the way things have been going nothing is outside the realm of possibility. Now before we spill the beans allows us once again to issue our standard disclaimer that . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.